Irene Larripa

Research interests

Publications

• Elevated levels of damage-associated molecular patterns HMGB1 and S100A8/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis

  Frontiers in Immunology · 2024 · 10.3389/fimmu.2024.1365015

• GSTM1 and GSTP1 , but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response

  Cancer Epidemiology · 2016 · 10.1016/j.canep.2016.07.008

• Phenotype–genotype correlations in hemophilia A carriers are consistent with the binary role of the phase between F8 and X‐chromosome inactivation

  Journal of Thrombosis and Haemostasis · 2015 · 10.1111/jth.12854

• Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy

  Blood Cells Molecules and Diseases · 2014 · 10.1016/j.bcmd.2013.09.002

• Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B

  Thrombosis and Haemostasis · 2012 · 10.1160/th12-05-0302

• Eighteen Years of Molecular Genotyping the Hemophilia Inversion Hotspot: From Southern Blot to Inverse Shifting-PCR

  International Journal of Molecular Sciences · 2011 · 10.3390/ijms12107271

• Partial and total monosomal karyotypes in myelodysplastic syndromes: Comparative prognostic relevance among 421 patients

  American Journal of Hematology · 2011 · 10.1002/ajh.22034

• Topoisomerase II-Mediated DNA Damage Is Differently Repaired during the Cell Cycle by Non-Homologous End Joining and Homologous Recombination

  PLoS ONE · 2010 · 10.1371/journal.pone.0012541

• Genotoxicity of glyphosate assessed by the comet assay and cytogenetic tests

  Environmental Toxicology and Pharmacology · 2009 · 10.1016/j.etap.2009.02.001

• Developing a new generation of tests for genotyping hemophilia‐causative rearrangements involving int22h and int1h hotspots in the factor VIII gene

  Journal of Thrombosis and Haemostasis · 2008 · 10.1111/j.1538-7836.2008.02926.x

• Genotyping the Hemophilia Inversion Hotspot by Use of Inverse PCR

  Clinical Chemistry · 2005 · 10.1373/clinchem.2004.046490

• Homeologous recombination between AluSx-sequences as a cause of hemophilia

  Human Mutation · 2004 · 10.1002/humu.9288

• Spontaneous Chromosome Aberrations in Fanconi's Anemia Patients are Located at Fragile Sites and Acute Myeloid Leukemia Breakpoints

  Hereditas · 2004 · 10.1111/j.1601-5223.1994.00047.x

• Cryptic t(4;11) encoding MLL-AF4 due to insertion of 5′ MLL sequences in chromosome 4

  Leukemia · 2001 · 10.1038/sj.leu.2402050

• Chromosomal aberrations in human lymphocytes exposed in vitro to enrofloxacin and ciprofloxacin

  Toxicology Letters · 1999 · 10.1016/s0378-4274(98)00230-6

• Chromosomal damage in workers occupationally exposed to chronic low level ionizing radiation

  Toxicology Letters · 1995 · 10.1016/0378-4274(94)03204-k

• Mutagenic bioassay of certain pharmacological drugs: III. Metronidazole (MTZ)

  Mutation research. Fundamental and molecular mechanisms of mutagenesis · 1994 · 10.1016/0027-5107(94)90230-5

• Genotoxic activity of azidothymidine (AZT) in in vitro systems

  Mutation Research/Genetic Toxicology · 1994 · 10.1016/0165-1218(94)90127-9

• Characterization of IIB‐MEL‐J: A New and Highly Heterogenous Human Melanoma Cell Line

  Pigment Cell Research · 1989 · 10.1111/j.1600-0749.1989.tb00246.x

• Thirteenfold increase of chromosomal aberrations non-randomly distributed in chagasic children treated with nifurtimox

  Mutation Research/Genetic Toxicology · 1989 · 10.1016/0165-1218(89)90165-1

• Assessment of cytogenetic damage in chagasic children treated with benznidazole

  Mutation Research/Genetic Toxicology · 1988 · 10.1016/0165-1218(88)90163-2

• Mutagenic bioassay of certain pharmacological drugs I. Thiabendazole (TBZ)

  Mutation Research/Genetic Toxicology · 1987 · 10.1016/0165-1218(87)90107-8

Current projects

No projects listed.